242 related articles for article (PubMed ID: 22767894)
1. Shear-activated nanotherapeutics for drug targeting to obstructed blood vessels.
Korin N; Kanapathipillai M; Matthews BD; Crescente M; Brill A; Mammoto T; Ghosh K; Jurek S; Bencherif SA; Bhatta D; Coskun AU; Feldman CL; Wagner DD; Ingber DE
Science; 2012 Aug; 337(6095):738-42. PubMed ID: 22767894
[TBL] [Abstract][Full Text] [Related]
2. Medicine. Leveraging shear stress to bust clots with nanoparticles.
Lavik E; Ustin J
Science; 2012 Aug; 337(6095):658-9. PubMed ID: 22879494
[No Abstract] [Full Text] [Related]
3. The shear stress of busting blood clots.
Wootton DM; Alevriadou BR
N Engl J Med; 2012 Oct; 367(14):1361-3. PubMed ID: 23034026
[No Abstract] [Full Text] [Related]
4. Targeted drug delivery to flow-obstructed blood vessels using mechanically activated nanotherapeutics.
Korin N; Gounis MJ; Wakhloo AK; Ingber DE
JAMA Neurol; 2015 Jan; 72(1):119-22. PubMed ID: 25365638
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic fibrinolysis through selective dissolution of nascent clots by tPA-carrying erythrocytes.
Murciano JC; Medinilla S; Eslin D; Atochina E; Cines DB; Muzykantov VR
Nat Biotechnol; 2003 Aug; 21(8):891-6. PubMed ID: 12845330
[TBL] [Abstract][Full Text] [Related]
6. Thrombi--beware of red cells bearing gifts.
Ouriel K
Nat Biotechnol; 2003 Aug; 21(8):871-2. PubMed ID: 12894199
[No Abstract] [Full Text] [Related]
7. [Local thrombolysis in peripheral arterial occlusion].
Hess H
Herz; 1989 Feb; 14(1):12-21. PubMed ID: 2522076
[TBL] [Abstract][Full Text] [Related]
8. Treatment of superior mesenteric and portal vein thrombosis with direct thrombolytic infusion via an operatively placed mesenteric catheter.
Kaplan JL; Weintraub SL; Hunt JP; Gonzalez A; Lopera J; Brazzini A
Am Surg; 2004 Jul; 70(7):600-4. PubMed ID: 15279182
[TBL] [Abstract][Full Text] [Related]
9. Splenic and superior mesenteric artery thrombolytic infusion therapy for acute portal and mesenteric vein thrombosis.
Safieddine N; Mamazza J; Common A; Prabhudesai V
Can J Surg; 2007 Feb; 50(1):68-9. PubMed ID: 17391622
[No Abstract] [Full Text] [Related]
10. [Fibrinolytic therapy in mesenteric venous thrombosis: experimental study in rats].
Uccheddu A; Murgia C; Licheri S; Dazzi C; Scattone S; Cagetti M
Chir Patol Sper; 1984 Dec; 32(6):243-8. PubMed ID: 6571558
[No Abstract] [Full Text] [Related]
11. The successful use of low-dose recombinant tissue plasminogen activator for treatment of intracardiac/pulmonary thrombosis during liver transplantation.
Boone JD; Sherwani SS; Herborn JC; Patel KM; De Wolf AM
Anesth Analg; 2011 Feb; 112(2):319-21. PubMed ID: 21127275
[TBL] [Abstract][Full Text] [Related]
12. A road to bring Brij52 back to attention: Shear stress sensitive Brij52 niosomal carriers for targeted drug delivery to obstructed blood vessels.
Arjmand S; Pardakhty A; Forootanfar H; Khazaeli P
Med Hypotheses; 2018 Dec; 121():137-141. PubMed ID: 30396467
[TBL] [Abstract][Full Text] [Related]
13. Successful thrombolysis of an aortic-arch thrombus in a patient after mesenteric embolism.
Hausmann D; Gulba D; Bargheer K; Niedermeyer J; Comess KA; Daniel WG
N Engl J Med; 1992 Aug; 327(7):500-1. PubMed ID: 1625748
[No Abstract] [Full Text] [Related]
14. An ultrasound-responsive nano delivery system of tissue-type plasminogen activator for thrombolytic therapy.
Uesugi Y; Kawata H; Jo J; Saito Y; Tabata Y
J Control Release; 2010 Oct; 147(2):269-77. PubMed ID: 20696194
[TBL] [Abstract][Full Text] [Related]
15. Antithrombotic effect of MCI-9042, a new antiplatelet agent on experimental thrombosis models.
Hara H; Kitajima A; Shimada H; Tamao Y
Thromb Haemost; 1991 Oct; 66(4):484-8. PubMed ID: 1796400
[TBL] [Abstract][Full Text] [Related]
16. Antithrombotic effects of acetylsalicylic acid (ASA) and pentoxifylline in laser-induced thrombosis in rat mesenteric vessels.
Weichert W; Breddin HK
Vasa; 1985; 14(3):280-4. PubMed ID: 3840307
[No Abstract] [Full Text] [Related]
17. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).
Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J
Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138
[TBL] [Abstract][Full Text] [Related]
18. Fluid shear stress increases the intra-cellular storage pool of tissue-type plasminogen activator in intact human conduit vessels.
Sjögren LS; Gan L; Doroudi R; Jern C; Jungersten L; Jern S
Thromb Haemost; 2000 Aug; 84(2):291-8. PubMed ID: 10959703
[TBL] [Abstract][Full Text] [Related]
19. [Shear-activated nanotherapeutics. Are we witnessing a breakthrough in the treatment of thrombosis and atherosclerosis?].
Wasilewski J; Poloński L
Kardiol Pol; 2012; 70(8):876. PubMed ID: 22933231
[No Abstract] [Full Text] [Related]
20. Inactivation of plasminogen activator inhibitor-1 accelerates thrombolysis of a platelet-rich thrombus in rat mesenteric arterioles.
Rupin A; Martin F; Vallez MO; Bonhomme E; Verbeuren TJ
Thromb Haemost; 2001 Dec; 86(6):1528-31. PubMed ID: 11776323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
